We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

288 hedge funds and large institutions have $2.85B invested in Amedisys in 2024 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 93 increasing their positions, 104 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 32

18% more funds holding in top 10

Funds holding in top 10: 11 → 13 (+2)

2% more funds holding

Funds holding: 283 → 288 (+5)

0.07% more ownership

Funds ownership: 94.92% → 94.99% (+0.07%)

0% less capital invested

Capital invested by funds: $2.86B → $2.85B (-$5.8M)

11% less repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 104

82% less call options, than puts

Call options by funds: $17.1M | Put options by funds: $94.3M

Holders
288
Holders Change
+5
Holders Change %
+1.77%
% of All Funds
4.16%
Holding in Top 10
13
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+18.18%
% of All Funds
0.19%
New
42
Increased
93
Reduced
104
Closed
32
Calls
$17.1M
Puts
$94.3M
Net Calls
-$77.2M
Net Calls Change
-$8.21M

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$96.9M
2
FCM
Farallon Capital Management
California
+$27.9M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$19.4M
4
LP
LMR Partners
United Kingdom
+$18.5M
5
SGCM
Sand Grove Capital Management
United Kingdom
+$17.5M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$32.3M
2
PWAM
Park West Asset Management
California
-$29.6M
3
WP
Woodline Partners
California
-$19.5M
4
MAM
Melqart Asset Management
United Kingdom
-$18.9M
5
Boston Partners
Boston Partners
Massachusetts
-$18.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Nomura Asset Management
226
Nomura Asset Management
Japan
$21.1K – – –
TCM
227
TD Capital Management
Tennessee
$18.3K +$18.5K +199 New
GI
228
Gradient Investments
Minnesota
$17.3K +$17.4K +188 New
RI
229
Ridgewood Investments
New Jersey
$16K +$16.1K +174 New
Allspring Global Investments
230
Allspring Global Investments
North Carolina
$14.3K +$3.15K +34 +28%
BCV
231
Banque Cantonale Vaudoise
Switzerland
$14K -$46.4K -500 -77%
VWM
232
Venturi Wealth Management
Texas
$13.6K +$9.09K +98 +196%
JWM
233
Janiczek Wealth Management
Colorado
$12.9K – – –
MPWT
234
MassMutual Private Wealth & Trust
Connecticut
$12.6K +$3.34K +36 +36%
JWA
235
JFS Wealth Advisors
Pennsylvania
$12.5K – – –
RA
236
Rise Advisors
New York
$11.5K – – –
MWM
237
Mascoma Wealth Management
New Hampshire
$11.5K +$11.6K +125 New
AF
238
Allworth Financial
California
$10.5K +$6.03K +65 +151%
SPIA
239
Steward Partners Investment Advisory
New York
$10.5K +$1.3K +14 +14%
CIBC Private Wealth Group
240
CIBC Private Wealth Group
Georgia
$9.72K – – –
BIA
241
Bell Investment Advisors
California
$9.55K +$2.41K +26 +33%
SWM
242
Spire Wealth Management
Virginia
$9.55K – – –
FFL
243
Financial Freedom LLC
Ohio
$9.18K – – –
FMTCOCP
244
Farmers & Merchants Trust Co of Chambersburg PA
Pennsylvania
$9K – – –
FDCDDQ
245
Federation des caisses Desjardins du Quebec
Quebec, Canada
$7.8K – – –
FFA
246
Farther Finance Advisors
California
$7.15K +$3.06K +33 +80%
HCP
247
Hexagon Capital Partners
Arkansas
$6.88K – – –
SAM
248
Smartleaf Asset Management
Massachusetts
$6.04K +$3.25K +35 +117%
Bessemer Group
249
Bessemer Group
New Jersey
$6K -$70.1K -756 -91%
BFEC
250
Benjamin F. Edwards & Company
Missouri
$5K -$1.67K -18 -24%
8 9
10
11 12

AMED Hedge Fund Activity: Q2 2024 in Review

288 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2024, worth a combined $2.85B — down 0.2% from $2.86B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new AMED positions and 32 closed out — a net gain of 10 holders — while 93 added to existing stakes and 104 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $96.9M. The largest seller was Millennium Management, cutting an estimated $32.3M.

  • 288 institutional investors held Amedisys (AMED) as of Q2 2024, up from 283 in Q1 2024.
  • Funds reported $2.85B of Amedisys stock for Q2 2024, down 0.2% quarter-over-quarter.
  • 42 funds opened new Amedisys positions in Q2 2024 and 32 closed out, a net change of +10 holders.
  • The largest Amedisys buyer in Q2 2024 was Goldman Sachs, an estimated $96.9M added.
  • The largest Amedisys seller in Q2 2024 was Millennium Management, an estimated $32.3M sold.

Based on aggregated 13F filings for Q2 2024.